DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Artículo científico (JournalArticle)
The anticancer activity of bovine lactoferrin is reduced by deglycosylation and it follows a different pathway in cervix and colon cancer cells
Bovine lactoferrin (bLF) is a glycosylated protein with purported beneficial properties. The aim of this work was to determine the role of bLF glycosylation in the adhesion, internalization, and growth inhibition of cancer cells. The viability of cervix (HeLa) and colon (Caco-2) cancer cells (MTT assay and epifluorescence microscopy) was inhibited by bLF, while deglycosylated bLF (bLFdeg) had no effect. Adhesion to cell surfaces was quantified by immunofluorescence assay and showed that bLF was able to bind more efficiently to both cell lines than bLFdeg. Microscopic observations indicated that bLF glycosylation favored bLF binding to epithelial cells and that it was endocytosed through caveolin-1-mediated internalization. In addition, the mechanism of action of bLF on cancer cell proliferation was investigated by determining the amount of phosphorylated intermediates of signaling pathways such as epidermal growth factor receptor (EGFR), extracellular signal-regulated kinase (ERK) and protein kinase B (known as Akt). Chemoluminescence immunoassay of phosphorylated intermediates showed that bLF inhibited Akt phosphorylation, consistent with its growth inhibiting activity. This assay also indicated that the bLF receptor/signaling pathways may be different in the two cell lines, Caco-2 and HeLa. This work confirmed the effect of glycosylated bLF in inhibiting cancer cell growth and that glycosylation is required for optimal surface adhesion, internalization, and inhibition of the ERK/Akt pathway of cell proliferation through glycosylated cell surface receptors., The project was supported by Spanish Ministry of Science and Innovation, grant RTI2018-097982-B-I00, Grant PID2022-136874OB-C33 funded by MCIN/AEI/doi.org/10.13039/501100011033, Severo Ochoa Accreditation CEX2021-001189-S and Generalitat Valenciana grant Prometeo CIPROM_2021_082. Ramirez-Sánchez, D.A. was recipient of a PhD scholarship from CONACyT MEXICO (Ref. 291250) and she was supported by a grant of the Fundación Carolina-SEGIB, Spain., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX 2021-001189-S), Peer reviewed
Proyecto:
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 RTI2018-097982-B-I00
,
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023 PID2022-136874OB-C33
,
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023 CEX 2021-001189-S
DOI: http://hdl.handle.net/10261/352199, https://api.elsevier.com/content/abstract/scopus_id/85187168166
HANDLE: http://hdl.handle.net/10261/352199, https://api.elsevier.com/content/abstract/scopus_id/85187168166